Regulatory Press Releases

Santen Pharmaceutical Co., Ltd., the leader in ophtalmicdrug development, has selected ArisGlobal to create a single global safety database and improve the efficiency and quality of their global safety vigilance processes. Santen Pharmaceutical’s safety suite will include ArisGlobal’s LifeSphere® MultiVigilance (LSMV), LifeSphere® Reporting and Analytics and LifeSphere® Intake and Triage solutions to automate key safety vigilance activities, reduce costs, and increase compliance.

ArisGlobal today announced details of its annual Life Sciences Technology Summit (AGLSTS 2019), taking place October 1st – 3rd at the Miami Beach EDITION hotel in Miami Beach, Florida. The 3-day event will bring together senior executives, IT and business practitioners, and industry experts across drug safety, regulatory affairs, clinical development, and medical affairs to discuss how a unified platform and automation technology can transform the drug development process.

ArisGlobal Safety Experts to Present “Supporting Life Science Industry to Meet the New Regulation Challenges” at 9th Asia Pharma R&D Leaders – Pharma & Healthcare

LifeSphere Publishing is an advanced, ,multi-tenant cloud submissions management system that enables life science organizations to easily compile, publish, and validate regulatory submissions with full support for all major global eCTD requirements

LifeSphere EasyDocs is a highly configurable, advanced cloud platform architected to streamline and unify enterprise document management and provide continuity of cross-functional workflows across the full drug development process

ArisGlobal Safety Experts to Present “Supporting Life Science Industry to Meet the New Regulation Challenges” at 9th Asia Pharma R&D Leaders – Pharma & Healthcare

ArisGlobal Safety Experts to Present “Supporting Life Science Industry to Meet the New Regulation Challenges” at 9th Asia Pharma R&D Leaders – Pharma & Healthcare

ArisGlobal, LLC, a leading provider of integrated cloud-based software solutions for life sciences, will present a session titled “Precision Pharmacovigilance: Is this the Way Forward?” at the upcoming World Drug Safety Congress Europe conference to be held in Amsterdam from September 10-11, 2018.

ArisGlobal selected as preferred partner by Celegence, a global regulatory affairs services provider, as its preferred partner for RIMS and IDMP Business Process-as-a-Service Offering enabling Life Sciences companies to leverage an innovative, efficient and cost-effective model for regulatory compliance. Read more

ArisGlobal’s session on July 2 at World Congress on Regulatory Affairs for Medical Devices, “Can Medical Devices Learn from Pharma: Shared Challenges, Similar Opportunities,” will focus on how regulatory information management data can be viewed as an asset, creating opportunities for automation and productivity gains.